Prevention of bleomycin-induced pulmonary fibrosis after adenovirus- mediated transfer of the bacterial bleomycin resistance gene

Journal of Clinical Investigation

Volumn 99, Issue 4, 1997, Pages 608-617

  Tran, Phuong Lan ^a,e   Weinbach, Jérôme ^b   Opolon, Paule ^a   Linares Cruz, Gustavo ^c   Reynes, Jean Paul ^d   Grégoire, Anne ^a   Kremer, Eric ^a   Durand, Henri ^d   Perricaudet, Michel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c Inst de Genet Moléculaire   (France)

^d Laboratoires CAYLA   (France)

^e INSERM   (France)

Author keywords

bleomycin; gene transfer; mouse lung; pulmonary fibrosis; Streptoalloteichus hindustanus ble

Indexed keywords

BLEOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BASEMENT MEMBRANE; DRUG INDUCED DISEASE; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG FIBROSIS; LUNG FUNCTION; LUNG TOXICITY; PRIORITY JOURNAL; TRANSGENE;

EID: 0001296471     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119203     Document Type: Article

References (52)

1. Cooper, J.A., A.C. White, and R.A. Matthay. 1986. Drug-induced pulmonary disease. Part I: cytotoxic drugs. Am. Rev. Resp. Dis. 133:321-340.
2. Umezawa, T., H. Takeuchi, and Y. Okami. 1966. New antibiotics, bleomycin A and B. J. Antibiot. (Tokyo). 19:200-209.
3. Ichikawa, T., I. Nakano, and I. Hirokawa. 1969. Bleomycin treatment of tumors of the penis and scrotum. J. Urol. 102:699-703.
4. Blum, R.H., S.K. Carter, and K. Agree. 1973. A clinical review of bleomycin: a new antineoplastic agent. Cancer. 31:903-914.
5. Hussar, D.A. 1974. New drugs of 1973. Am. J. Pharm. Sci. Supporting Public Health. 146:37-58.
6. Bennett, J.M., and S.D. Reich. 1979. Bleomycin. Ann. Intern. Med. 90: 945-948.
7. Muggia, F.M., A.C. Louie, and B.I. Sikic. 1983. Pulmonary toxicity of antitumor agents. Cancer Treat. Rep. 10:221-243.
8. Bedrossian, C.W.M., M.A. Lunda, B. Mackay, and B. Lichtiger. 1973. Ultrastructure of pulmonary bleomycin toxicity. Cancer (Phila.). 32:44-51.
9. Adamson, I.Y.R., and P.H. Bowden. 1974. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77:185-196.
10. Colby, T.V., and A.C. Churg. 1986. Patterns of pulmonary fibrosis. Pathol. Annu. 21:277-309.
11. Bitterman, P.B., S.I. Rennard, S. Adelberg, and R.G. Crystal. 1983. Role of fibronectin as a growth factor for fibroblasts. J. Cell Biol. 97:1925-1932.
12. Hoyt, D.G., and J.S. Lazo. 1988. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246: 765-771.
13. Kovacs, E., and J. Kelley. 1986. Intra-alveolar release of a competence-type growth factor after lung injury. Am. Rev. Respir. Dis. 133:68-72.
14. Reiser, K.M., and J.A. Last. 1986. Early cellular events in pulmonary fibrosis. Exp. Lung Res. 10:331-355.
15. Kovacs, E.J. 1991. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue, Immunol. Today. 12:17-23.
16. King, S.L., A.C. Lichtler, D.W. Rowe, W. Xie, G.L. Long, M.P. Absher, and K.R. Cutroneo. 1994. Bleomycin stimulates Pro-1(I) collagen promoter through transforming growth factor response element by intracellular and extracellular signaling. J. Biol. Chem. 269:13156-13161.
17. Lazo, J.S., and C.J. Humphreys. 1983. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc. Natl. Acad. Sci. USA. 80:3064-3068.
18. Piguet, P.F., H. Rosen, C. Vesin, and G.E. Grau. 1993. Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am. Rev. Respir. Dis. 147:435-441.
19. Giri, S.N., D.M. Hyde, and MA. Hollinger. 1993. Effect of antibody to transforming growth factor-β on bleomycin induced accumulation of lung collagen in mice. Thorax. 48:959-966.
20. Piguet, P.F., and C. Vesin. 1994. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur. Respir. J. 7:515-518.
21. Drocourt, D., T. Calmels, J.P. Reynes, M. Baron, and G. Tiraby. 1990. Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistance. Nucleic Acid Res. 18: 4009.
22. Gatignol, A.H., H. Durand, and G. Tiraby. 1988. Bleomycin resistance conferred by a drug binding protein. FEBS Lett. 230:171-175.
23. Dumas, P., M. Bergdoll, C. Cagnon, and J.M. Masson. 1994. Crystal structure and site-directed mutagenesis of a bleomycin resistance protein and their significance for drug sequestering. EMBO (Eur. Mol Biol. Organ.) J. 13: 2483-2492.
24. Weinbach J., A. Camus, J. Bara, P. Dumont, M. Julian, S. Cros, C. Babinet, and G. Tiraby. 1996. Transgenic mice expressing the Sh ble bleomycin-resistance gene are protected against bleomycin-induced pulmonary fibrosis. Cancer Res. In press.
25. Van Doren, K., and Y. Gluzman. 1984. Efficient transformation of human fibroblastics by adenovirus-simian 40 recombinants. Mol. Cell. Biol. 4: 1653-1656.
26. Van Doren, K., D. Hanahan, and Y. Gluzman. 1984. Infection of eucaryotic cells by helper-independent recombinant adenovirus: early region 1 is not obligatory for integration of viral DNA. J. Virol. 50:606-614.
27. Stratford-Perricaudet, L.D., M. Levrero, J.F. Chasse, M. Perricaudet, and P. Briand. 1990. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1: 241-256.
28. Rosenfeld, M.A., K. Yoshimura, B.C. Trapnell, K. Yoneyama, E.R. Rosenthal, W. Dalemans, M. Fukayama. J. Bargon, L.E. Stier, L.D. Stratford-Perricaudet, et al. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 68:143-155.
29. Kremer, E.J., and M. Perricaudet. 1995. Adenovirus and adeno-associated virus mediated gene transfer. Br. Med. Bull. 51:31-44.
30. Jaffe, H.A., C. Danel, G. Longenecker, M. Metzger, Y. Setoguchi, M.A. Rosenfeld, T.W. Gant, S.S. Thorgeirsson, L.D. Stratford-Perricaudet, M. Perricaudet, et al. 1992. Hepatic gene transfer therapy: replication deficient, recombinant adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1:372-384.
31. Ragot, T., N. Vincent, P. Chafey, E. Vigne, H. Gilgenkrantz, D. Couton, J. Cartaud, P. Briand, J.C. Kaplan, M. Perricaudet, and A. Kahn. 1993. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (Lond.). 361:647-650.
32. Herz, J., and R.D. Gerard. 1993. Adenovirus-mediated transfer of low lipoprotein receptor gene accurately accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA. 90:2812-2816.
33. Shenks, T., and J. Williams. 1984. Genetics analysis of adenoviruses. Curr. Top. Microbiol. Immunol. 111:1-39.
34. Graham, F.L., J. Smiley, W.C. Russel, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from adenovirus type 5. J. Gen. Virol. 36:59-72.
35. Mulsant, P., A. Gatignol, M. Dalens, and G. Tiraby. 1988. Phleomycin resistance as a dominant selectable marker in CHO cells. Somatic Cell Mol. Genet. 14:243-252.
36. Stratford-Perricaudet, L.D., I. Makeh, M. Perricaudet, and P. Briand. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
37. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
38. Tran, P.L., and M.A. Deugnier. 1985. Intracellular localization of 12-O-3-N-dansylamino TPA in C3H/10T1/2 mouse cell line. Carcinogenesis (Oxf.). 6: 433-439.
39. Raap, A.K., M.P.C. van de Corput, R.A.W. Vervenne, van R.P.M. Gijlswijk, H.J. Tanke, and J. Wiegant. 1995. Ultra-sensitive FISH using peroxidase-mediated deposition of biotin-or fluorochrome tyramides. Hum. Mol. Genet. 4:529-534.
40. Linares-Cruz, G., G. Millot, P. De Cremoux, J. Vassy, B. Olofsson, J.P. Rigaut, and F. Calvo. 1995. Combined analysis of in situ hybridization, cell cycle and structural markers using reflectance and immunofluorescence confocal microscopy. Histochem. J. 27:15-23.
41. Harrison, J.H., and J.S. Lazo. 1987. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J. Pharmacol. Exp. Ther. 243:1185-1194.
42. Tran, P.L., M. Grouselle, D. Georgescauld, and M.J. Brienne. 1991. Direct visualization by fluorescence video microscopy of the subcellular localization of a new derivative phorbol-12,13-dibutanoate. Cell. Physiol. Biochem. 1: 31-45.
43. Calmels, T.P.G., J.S. Mistry, S.C. Watkins, P.D. Robbins, R. McGuire, and J.S. Lazo. 1993. Nuclear localization of bacterial Streptoalloteichus hindustanus bleomycin resistance protein in mammalian cells. Mol. Pharmacol. 44: 1135-1141.
44. Dong, J.Y., D. Wang, F.W. Van Ginkel, D.W. Pascual, and R.A. Frizzell. 1996. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum. Gene Ther. 7:319-331.
45. Lazo, J.S. 1981. Angiotensin converting enzyme in mice during subacute bleomycin administration. Toxicol. Appl. Pharmacol. 59:395-404.
46. Collins, J.F., B. McCullough, J.J. Coalson, and W.G. Johanson. 1981. Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons. Am. Rev. Respir. Dis. 123:305-312.
47. Brody, S.L., M. Metzger, C. Danel, M.A. Rosenfeld, and R.G. Crystal. 1994. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5:821-836.
48. Quinones, F., and E. Crouch. 1986. Biosynthesis of interstitial and basement membrane collagens in pulmonary fibrosis. Am. Rev. Respir. Dis. 134: 1163-1171.
49. Moseley, P.L., C. Hemken, and G.W. Hunninghake. 1986. Augmentation of fibroblast proliferation by bleomycin. J. Clin. Invest. 78:1150-1154.
50. Lazo, J.S., D.G. Hoyt, S.M. Sebti, and B.R. Pitt. 1990. Bleomycin: a pharmacological tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol. Ther. 47:347-358.
51. Tran, P.L., T. Ragot, P.E. Watkins, A.J. Morgan, and M. Perricaudet. 1992. Detection by PCR of the gp-340-expressing recombinant adenovirus (Ad) DNA and transcripts in tissues of cottontop tamarins vaccinated against EBV-induced lymphomas. Vth International Symposium on Epstein-Barr Virus and Associated Diseases. 144:P.V.8. (Abstr.)
52. Kass-Eisler, A., E. Falck-Pedersen, D.H. Elfenbein, M. Alvira, P.M. Buttrick, and L.A. Leinwand. 1994. The impact on developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:395-402.